6-32189827-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002586.5(PBX2):āc.89A>Gā(p.Glu30Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000405 in 1,578,888 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002586.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PBX2 | NM_002586.5 | c.89A>G | p.Glu30Gly | missense_variant | 1/9 | ENST00000375050.6 | |
PBX2 | XM_047418839.1 | c.-183A>G | 5_prime_UTR_variant | 1/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PBX2 | ENST00000375050.6 | c.89A>G | p.Glu30Gly | missense_variant | 1/9 | 1 | NM_002586.5 | P1 | |
PBX2 | ENST00000478678.5 | n.116A>G | non_coding_transcript_exon_variant | 1/6 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000404 AC: 6AN: 148498Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000186 AC: 4AN: 214708Hom.: 0 AF XY: 0.0000169 AC XY: 2AN XY: 118560
GnomAD4 exome AF: 0.0000405 AC: 58AN: 1430390Hom.: 1 Cov.: 31 AF XY: 0.0000394 AC XY: 28AN XY: 711102
GnomAD4 genome AF: 0.0000404 AC: 6AN: 148498Hom.: 0 Cov.: 31 AF XY: 0.0000277 AC XY: 2AN XY: 72330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 24, 2022 | The c.89A>G (p.E30G) alteration is located in exon 1 (coding exon 1) of the PBX2 gene. This alteration results from a A to G substitution at nucleotide position 89, causing the glutamic acid (E) at amino acid position 30 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at